Trevena, Inc. (TRVN)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Discovering and Developing Pharmaceutical Products	3.13M	-418.00K	567.00K	3.07M	31.00K
Discovering and Developing Pharmaceutical Products Growth	-	-	-81.52%	9800.00%	-99.46%
Total	3.13M	-418.00K	567.00K	3.07M	31.00K
Total Growth	-	-	-81.52%	9800.00%	-99.46%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
United States	3.13M	-418.00K	567.00K	3.07M	31.00K
United States Growth	-	-	-81.52%	9800.00%	-99.46%
Total	3.13M	-418.00K	567.00K	3.07M	31.00K
Total Growth	-	-	-81.52%	9800.00%	-99.46%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error